Back
Invesco BulletShares 2033 Corporate Bond ETF Vs. Aligos Therapeutics Industry Stock Comparison
Sell
1
BSCX
Invesco BulletShares 2033 Corporate Bond ETF
Last Price:
$20.59
Seasonality Move:
-2.65%
Buy
69
ALGS
Aligos Therapeutics
Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
1
Invesco BulletShares 2033 Corporate Bond ETF (BSCX)
is a Sell
Is Invesco BulletShares 2033 Corporate Bond ETF a Buy, Sell or Hold?
-
The current Invesco BulletShares 2033 Corporate Bond ETF [BSCX] share price is $20.59. The Score for BSCX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
BSCX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BSCX Stock Price Chart
What is Invesco BulletShares 2033 Corporate Bond ETF's stock price today?
-
The Invesco BulletShares 2033 Corporate Bond ETF share price today is $20.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BSCX is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BSCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 35.78 | Sell |
Chaikin Money Flow: | -255885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.68 - 21.12) | Sell |
Bollinger Bands (100): | (20.86 - 21.52) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.14 | Buy |
Relative Strength Index (14 RSI): | 74.33 | Buy |
Chaikin Money Flow: | 210748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.82 - 40.1) | Buy |
Bollinger Bands (100): | (6.77 - 28.07) | Buy |
BSCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.63 | Sell |
20-day SMA: | 20.86 | Sell |
50-day SMA: | 20.9 | Sell |
200-day SMA: | 20.94 | Sell |
8-day EMA: | 20.66 | Sell |
20-day EMA: | 20.78 | Sell |
50-day EMA: | 20.93 | Sell |
200-day EMA: | 20.92 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.78 | Buy |
20-day SMA: | 36.11 | Buy |
50-day SMA: | 23.97 | Buy |
200-day SMA: | 16.97 | Buy |
8-day EMA: | 40.32 | Buy |
20-day EMA: | 35.95 | Buy |
50-day EMA: | 27.43 | Buy |
200-day EMA: | 19.22 | Buy |
Invesco BulletShares 2033 Corporate Bond ETF Earnings Growth & BSCX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Invesco BulletShares 2033 Corporate Bond ETF Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |